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OBJECTIVE—We tested the hypothesis that short-term exer-
cise training improves hereditary insulin resistance by stimulat-
ing ATP synthesis and investigated associations with gene
polymorphisms.
RESEARCH DESIGN AND METHODS—We studied 24 nono-
bese ﬁrst-degree relatives of type 2 diabetic patients and 12
control subjects at rest and 48 h after three bouts of exercise. In
addition to measurements of oxygen uptake and insulin sensitiv-
ity (oral glucose tolerance test), ectopic lipids and mitochondrial
ATP synthesis were assessed using
1H and
31P magnetic reso-
nance spectroscopy, respectively. They were genotyped for
polymorphisms in genes regulating mitochondrial function,
PPARGC1A (rs8192678) and NDUFB6 (rs540467).
RESULTS—Relatives had slightly lower (P  0.012) insulin
sensitivity than control subjects. In control subjects, ATP syn-
thase ﬂux rose by 18% (P  0.0001), being 23% higher (P  0.002)
than that in relatives after exercise training. Relatives responding
to exercise training with increased ATP synthesis (19%, P 
0.009) showed improved insulin sensitivity (P  0.009) compared
with those whose insulin sensitivity did not improve. A polymor-
phism in the NDUFB6 gene from respiratory chain complex I
related to ATP synthesis (P  0.02) and insulin sensitivity
response to exercise training (P  0.05). ATP synthase ﬂux
correlated with O2 uptake and insulin sensitivity.
CONCLUSIONS—The ability of short-term exercise to stimu-
late ATP production distinguished individuals with improved
insulin sensitivity from those whose insulin sensitivity did not
improve. In addition, the NDUFB6 gene polymorphism appeared
to modulate this adaptation. This ﬁnding suggests that genes
involved in mitochondrial function contribute to the response of
ATP synthesis to exercise training. Diabetes 58:1333–1341,
2009
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ifestyle intervention is the recommended strategy
for prevention of type 2 diabetes. First-degree
relatives of patients with type 2 diabetes (rela-
tives) have an increased risk of insulin resistance
and type 2 diabetes (1,2). Inherited and environmental
factors cause insulin resistance via intracellular lipid and
inﬂammatory mediators that interfere with insulin signal-
ing, leading to an impaired rise of glucose 6-phosphate
(G6P) due to reduced glucose transport/phosphorylation
(2,3). These alterations can coexist with excessive storage
of intramyocellular lipids (IMCLs) or hepatocellular lipids
(HCLs) and impaired mitochondrial function and/or num-
ber in insulin-resistant states such as aging (4), with free
fatty acid (FFA) elevation (5), and in some (6–8) but not
all (9,10) individuals at risk of or with type 2 diabetes.
Nondiabetic relatives with severe insulin resistance
present with elevated FFAs, IMCLs, and HCLs along with
impaired ATP synthesis possibly due to reduced mitochon-
drial contents (11). Inherited and acquired factors associ-
ate with gene expression of the respiratory chain
components, NDUFB6 and COX7A1, and their transcrip-
tional coactivators, peroxisome proliferator–activated re-
ceptor- coactivator-1/ (PGC-1/), which determine
maximum oxygen uptake (VO2max) and insulin action
(12,13). It remains unclear whether altered ATP synthesis
results from increased availability of lipids and/or adi-
pokines such as adiponectin, the nicotinamide phospho-
ribosyltransferase visfatin, and retinol-binding protein-4
(RBP-4) (14).
It is also uncertain whether such abnormalities are
reversible by exercising and/or occur independently of
effects on insulin action. Long-term endurance exercise
training increases insulin sensitivity in sedentary young
and elderly individuals (15), relatives (16), and glucose-
intolerant, obese, or type 2 diabetic individuals (17).
Exercise training for at least 4 weeks enhances fat oxida-
tion along with increased mitochondrial mass and enzyme
activities (18,19). However, little is known regarding the
time course and onset of changes in glucose and energy
metabolism independently of acute exercise effects.
We used magnetic resonance spectroscopy (MRS) to
measure in vivo ﬂux of inorganic phosphate (Pi)t oA T P
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DIABETES, VOL. 58, JUNE 2009 1333through ATP synthase (fATPase) as well as IMCLs and
HCLs before and after three bouts of cycling training to
test the following hypotheses: 1) increased fATPase is an
early event in the response to short-term exercise training,
2) responses of fATPase and insulin sensitivity are differ-
ent in relatives compared with healthy control subjects,
and 3) the responses are modulated by polymorphisms in
genes that are mutually linked to exercise capacity, energy
metabolism, and insulin sensitivity in epidemiological
studies.
RESEARCH DESIGN AND METHODS
Volunteers. We recruited healthy relatives of one (n  19) or two (n  5)
parents with type 2 diabetes, which was conﬁrmed by hyperglycemia, oral
antidiabetic medication, or insulin use. Twelve individuals matched for sex,
age, BMI, and physical activity were recruited as control subjects (Table 1). A
medical history was obtained, and the participants underwent a physical
examination. All participants were weight-stable over the 6 months before the
study. None of them was smoking or regularly performing intense exercise.
Study protocols. Volunteers gave written informed consent to participate in
the study, which was approved by the institutional ethics board and per-
formed according to the Declaration of Helsinki. All participants consumed an
isocaloric diet, refrained from any physical exercise for 3 days, and fasted for
12 h before the start of the studies. On day 1, participants underwent a
frequent-sampling 75-g oral glucose tolerance test (OGTT) and MRS. On day 2,
they performed exercise testing. On days 3 and 5, they exercised on a cycling
ergometer. On day 7, measurements of day 1 were repeated in identical
fashion.
Dietary assessment. Throughout the study, all volunteers maintained a
dietary plan reﬂecting an isocaloric diet in line with the American Diabetes
Association recommendations. Dietary intake over the last year and dietary
compliance were assessed with a modiﬁed interviewer-administered 107-item
food frequency questionnaire adjusted for local dietary habits (http://
www.uni-hohenheim.de/wwwin140/info/interaktives/foodfreq.htm). During the
1-week intervention, volunteers counted all food and beverages consumed,
using common household measures, to obtain 6-day dietary records. Nutrient/
ﬂuid intake on the days before the studies were analyzed using 24-h recalls. In
the evenings before the studies, participants consumed identically composed
carbohydrate-enriched dinners at identical times. On study days, participants
did not receive any calories except for the OGTT until completion of the MRS
measurements.
Genotyping. Genomic DNA was extracted from blood of all participants with
a QIAamp DNA Blood Mini kit (catalog no. 51106; Qiagen). Single nucleotide
polymorphisms (SNPs), rs540467 of NDUFB6 and rs8192678 (Gly482Ser)o f
PPARGC1A, were genotyped using allelic discrimination assays performed
with an ABI 7900 system (Applied Biosystems). The following assays were
used: for rs540467, Assay-on-Demand, C_2334430 (Applied Biosystems); and
for rs8192678, forward primer TGGAGAATTGTTCATTACTGAAATCACTGT
and reverse primer GGTCATCCCAGTCAAGCTGTTTT together with two
different probes, Vic-CAAGACCGGTGAACTG and Fam-ACAAGACCAGT
GAACTG, respectively.
OGTT. Participants drank a solution containing 75 g glucose, and venous
blood samples were collected before and in 30-min intervals for 150 min for
measurements of glucose, insulin, and C-peptide. Dynamic insulin sensitivity
was assessed by oral glucose insulin sensitivity (OGIS) using the 120-min
formula, which yields a measure of glucose clearance that has been widely
exploited and validated against whole-body insulin sensitivity obtained from
the euglycemic-hyperinsulinemic clamp (20). -Cell function was assessed
from the insulinogenic index (21).
MRS. Participants were studied in a 3-T magnetic resonance spectrometer
(Bruker, Bremen, Germany). A 10-cm circular double resonant
1H/
31P surface
coil was used for quantifying HCLs and phosphorus metabolites. A 28-cm
birdcage coil was positioned over the right lower leg for measuring IMCLs in
soleus and tibialis anterior muscles. For nonlocalized
31P MRS, the right calf
was positioned on the surface coil with the medial head of the right
gastrocnemius muscle in the coil center. The integrals of the region of
phosphomonoesters covering G6P (7.1–7.4 ppm), phosphodiesters (PDEs), Pi,
and phosphocreatine were measured from the ratio of integrated peak
intensities and -ATP resonance intensity in spectra without inversion and
saturation, assuming an ATP concentration of 5.5 mmol/l (Fig. 1). The
assumption of constant ATP before and after exercise training was supported
by unchanged ATP/PDE ratios (data not shown), because PDE levels remain
constant under similar conditions (22). Absolute quantiﬁcation would be
required to detect subtle changes of myocellular ATP concentrations, which
do not necessarily reﬂect actual fATPase. The saturation transfer experiment
(selective irradiation of -ATP) was used to measure the exchange rate (k1)
between Pi and ATP and to calculate fATPase from k1  [Pi] (5,8) (Fig. 1).
IMCLs and HCLs were determined within volumes of interest of 1.73 cm
3 (23)
and 27 cm
3 (5), respectively.
Habitual physical activity, exercise capacity, and training. Physical
activity was assessed by an interviewer-administered questionnaire on a scale
from 1 to 5 (low to high degree of activity) (24). Each participant performed
an incremental exhaustive exercise test on an electronically braked cycle
ergometer (Lode Excalibur Sport, Groningen, the Netherlands) at 70 revolu-
tions/min. Respiratory gas exchange measures were determined by open-air
spirometry (MasterScreen CPX; Ja ¨ger/Viasys, Wu ¨rzburg, Germany). The
breath-by-breath measures were recorded and averaged over an interval of
eight breath cycles. Heart rate was measured every 5 s (Polar Vantage NV
telemetry; Polar Electro, Kempele, Finland). To regulate load intensities of
training sessions according to the individual aerobic capacity, a ventilatory
threshold (respiratory compensation point [RCP]) was determined (25),
which marks the onset of hyperventilation during incremental exercise
training driven mainly by the onset of lactic acidosis. RCP was determined
independently by two investigators (intraclass correlation, r  0.9721) from 1)
the second upward inﬂection in the VE (minute ventilation) curve after the
ﬁrst break point at the anaerobic threshold, 2) an upward inﬂection in the
curve of VE/VCO2 (ventilatory equivalent for CO2), and 3) a downward
inﬂection in the curve of PETCO2 (end-tidal volume for CO2) during the time
course of respiratory gas exchange measure variables. The two training
sessions (days 2 and 5) consisted of 30 min in three 10-min bouts separated by
TABLE 1
Baseline clinical and laboratory characteristics of control subjects and ﬁrst-degree relatives of type 2 diabetic patients and relative
subgroups: RESP and NRES of ATP-synthesis to exercise training
Control Relatives RESP NRES
n (women/men) 12 (6/6) 24 (13/11) 10 (4/6) 14 (9/5)
Age (years) 37  11 (30–44) 40  12 (35–45) 41  15 (31–52) 39  11 (33–46)
Body weight (kg) 71  13 (63–79) 73  14 (68–79) 76  14 (65–86) 72  13 (64–79)
BMI (kg/m
2) 23  2 (22–25) 25  4 (24–27) 26  4 (23–29) 25  4 (22–27)
Waist-to-hip ratio 0.83  0.08 (0.78–0.88) 0.85  0.05 (0.83–0.87) 0.87  0.04 (0.84–0.90) 0.84  0.05 (0.81–0.87)
Systolic blood pressure (mmHg) 124  19 (112–135) 126  11 (121–130) 127  11 (119–135) 125  12 (118–132)
Diastolic blood pressure (mmHg) 82  10 (76–88) 83  8 (79–86) 82  8 (76–88) 84  8 (79–88)
A1C (%) 5.3  0.3 (5.1–5.5) 5.4  0.3 (5.3–5.6) 5.5  0.4 (5.2–5.7) 5.4  0.3 (5.3–5.6)
Triglycerides (mmol/l) 0.87  0.50 (0.53–1.20) 1.23  0.70 (0.94–1.53) 1.32  0.57 (0.91–1.73) 1.18  0.80 (0.72–1.64)
HDL cholesterol (mmol/l) 1.7  0.45 (1.4–2.0) 1.5  0.4 (1.3–1.6) 1.4  0.4 (1.1–1.7) 1.5  0.4 (1.3–1.7)
LDL cholesterol (mmol/l) 3.0  0.7 (2.5–3.4) 3.5  0.9 (3.1–3.9) 3.8  0.9 (3.2–4.4) 3.3  1.0 (2.8–3.9)
Physical activity (scale 1–5) 2.7  0.3 (2.5–2.9) 2.9  0.3 (2.7–3.0) 2.9  0.3 (2.6–3.1) 2.9  0.3 (2.7–3.1)
VO2max (ml  kg
1  min
1) 33.6  6.0 (29.8–37.5) 30.6  6.4 (27.8–33.3) 29.6  5.5 (25.7–33.6) 31.2  7.1 (27.1–35.3)
VO2RCP (ml  kg
1  min
1) 26.2  4.8 (23.1–29.2) 22.8  5.7 (20.4–25.2) 22.1  4.7 (18.7–25.4) 23.3  6.4 (19.6–27.0)
Data are means  SD (95% CI). NRES, not responding to exercise with stimulation of fATPase; RESP, responding to stimulation of fATPase.
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at RCP. Thus, the three bouts of exercise training comprised the exercise
testing and the two subsequent training sessions. All participants completed
exercise testing, and all training sessions, which were performed under
continuous supervision by a sports physiologist. Data analysis revealed
variable fATPase responses to exercise training among relatives compared
with control subjects. Relatives were therefore divided into two subgroups
based on the difference of fATPase between baseline and after exercise
training: responder (n  10) with (fATPaseafter – fATPasebefore) 	0 and
nonresponder (n  14) with (fATPaseafter – fATPasebefore) 0.
Analytical procedures. Plasma glucose was measured on a Glucose Ana-
lyzer II (Beckman Coulter; http://www.beckmancoulter.com). For FFA mea-
surement (Wako Chemicals USA; http://www.wakousa.com/), blood was
collected into vials containing orlistat to prevent in vitro lipolysis. Lactate was
determined enzymatically (Roche; http://www.roche.com/home.html), insulin
and C-peptide by double-antibody radioimmunoassay and RBP-4 and visfatin
in seven control subjects and eight relatives by ELISA (Phoenix Pharmaceu-
ticals, Karlsruhe, Germany; www.phoenixpeptide.com/), with inter- and intra-
assay coefﬁcients of variation of 
6% (5).
Statistics. OGIS and fATPase were deﬁned as the primary end points. The
sample size calculation was based on previous studies on fATPase using
false-positive (Z1.96, two-tailed) and false-negative error rates (Z0.84,
one-tailed), respectively. Data are presented as means  SD and 95% CIs (text
and tables) or means  SE (ﬁgures). Unpaired/paired two-tailed t tests were
used for between- and within-group comparisons as appropriate. Bivariate
correlations were assessed with a Pearson correlation coefﬁcients. Multiple
stepwise linear regression analysis was performed for the dependent vari-
ables, fATPase and OGIS, including BMI, waist-to-hip ratio, age, triglycerides,
FFAs, physical activity, VO2max, HCLs, IMCLs, and caloric intake and also for
changes in the above parameters during the study. All calculations were done
using SPSS for Windows (version 8; SPSS, Chicago, IL; http://www.spss.com).
Associations between genotypes and exercise responses for fATPase and
OGIS were analyzed with the 
2 test (NCSS Statistical Software, Kaysville,
UT).
RESULTS
Clinical characteristics, exercise testing, and dietary
intake. The groups showed similar sex distribution, age,
and fat mass and distribution (Table 1). Laboratory tests,
exercise performance, and physical activity including its
individual components (data not shown) were not different
between groups and subgroups. Energy and nutrient intake
were not different between groups before and during the 24 h
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FIG. 1.
31P magnetic resonance spectrum acquired at 3-T using a surface coil (repetition time  15 s, number of scans  16) positioned under the
calf muscle of one participant. The spectrum shows intramyocellular phosphomonoesters (PME) including G6P, Pi, PDEs, phosphocreatine (PCr),
and ATP. Inset:
31P spectra with saturation of -ATP (bottom) and with saturation mirrored around Pi (top), which was always used to account
and correct for direct saturation of the resonance frequency pulse.
TABLE 2
Nutrient intake obtained from 24-h dietary recalls in control subjects and relatives
Control subjects Relatives
Before After training Before After training
Caloric intake (kcal/day) 2,274  843 (1,738–2,809) 2,045  904 (1,470–2,619) 1,937  614 (1,671–2,203) 1,820  557 (1,579–2,061)
% of daily energy intake
Carbohydrate (%) 39  11 (32–46) 43  10 (37–50) 44  12 (39–49) 44  9 (40–48)
Fat (%) 40  10 (34–47) 37  8 (32–42) 37  10 (33–41) 35  8 (31–38)
Protein (%) 17  6 (14–21) 17  6 (13–20) 17  6 (15–20) 19  5 (16–21)
Saturated fat (%) 18  6 (14–21) 17  4 (15–19) 16  5 (14–18) 15  5 (13–17)
n-3 fatty acids (%) 1  0 (1–2) 1  1 (1–2) 1  1 (1–1) 1  0 (1–1)
n-6 fatty acids (%) 5  3 (3–7) 4  2 (3–5) 5  2 (4–6) 6  3 (5–7)
Cholesterol (g/day) 0.38  0.17 (0.27–0.50) 0.38  0.20 (0.26–0.51) 0.34  0.22 (0.25–0.44) 0.30  0.17 (0.22–0.37)
Data are means  SD (95% CI). Dietary data after training were not available from one relative who lost the dietary record. There were no
statistical differences within and between groups.
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similar nutrient composition (supplementary Table 1, avail-
able at http://diabetes.diabetesjournals.org/cgi/content/
full/db08-1240/DC1). Body weights did not change in
control subjects (before 71.50  12.82 vs. after 71.35 
12.75 kg) or in relatives (73.46  13.54 vs. 73.06  13.22
kg).
Metabolites, hormones, insulin sensitivity, and secretion.
Fasting plasma glucose did not differ between groups
(Table 3). The 2-h plasma glucose after oral glucose
loading was within the normal range, slightly higher in
relatives than in control subjects before (6.3  1.4 vs.
5.0  1.1 mmol/l, P  0.009) but not after exercise (4.8 
1.2 vs. 5.5  1.2 mmol/l). Plasma FFAs were comparable at
baseline but were higher in relatives after training (P 
0.019). C-peptide was higher in relatives before (P  0.006)
and after exercise training (P  0.031). Fasting plasma
insulin tended to be increased in relatives. In subgroups,
plasma RBP-4 (before training: control subjects 0.36 
0.12 and relatives 0.41  0.07 ng/ml; after training: 0.36 
0.08 and 0.43  0.09 ng/ml) and visfatin (before training:
control subjects 39  26 and relatives 29  9 ng/ml; after
training: 35  13 and 26  6 ng/ml) did not differ. At
baseline, OGIS was 13% lower (P  0.012) in relatives than
in control subjects and rose slightly in both control
subjects by 7% (P  0.05) and in relatives by 12% (P 
0.012) after training (Fig. 2). The quantitative insulin-
sensitivity check and insulinogenic indexes were compa-
rable before and after training in both groups (Table 3).
In subgroups, responding or not responding to exercise
with stimulation of fATPase, fasting glucose, lactate, insu-
lin, insulinogenic index C-peptide (Table 3), and 2-h post-
load plasma glucose (data not shown) were comparable
before and after training. Plasma FFAs were similar at
baseline and increased after exercise training by 39% in
nonresponders (P  0.008). OGIS was comparable at
baseline but increased only in responders upon exercise
training (P  0.009) (Fig. 2).
Intramyocellular phosphorus metabolism and ectopic
lipids. Baseline fATPase did not differ between groups
(control subjects 12.0  2.2 vs. relatives 11.1  2.9 mol 
ml
1  muscle
1  min
1) (Fig. 3). After training, fATPase
increased by 
18% (P  0.0001) only in control subjects
(14.2  2.5 mol  ml
1  muscle
1  min
1) and was 
23%
(P  0.002) higher than in relatives (10.9  3.0 mol  ml
1 
muscle
1  min
1), in whom it did not change upon
exercise training (Fig. 3). Similarly, k1 rose in control
subjects (P  0.001) but not in relatives (P  0.7). HCLs
TABLE 3
Responses of relatives and of RESP and NRES of ATP synthesis to exercise training
Before exercise After exercise
Glucose (mmol/l)
Control subjects 4.9  0.3 (4.7–5.1) 4.9  0.3 (4.7–5.1)
Relatives 5.0  0.4 (4.8–5.1) 5.0  0.4 (4.8–5.1)
RESP 5.0  0.4 (4.8–5.3) 5.0  0.4 (4.7–5.3)
NRES 4.9  0.4 (4.7–5.2) 5.0  0.5 (4.7–5.2)
Lactate (mmol/l)
Control subjects 1.1  0.3 (0.9–1.3) 1.0  0.2 (0.8–1.1)*
Relatives 1.5  0.5 (1.3–1.7)** 1.3  0.5 (1.0–1.5)*
RESP 1.3  0.5 (1.0–1.7) 1.2  0.3 (0.9–1.4)
NRES 1.6  0.4 (1.3–1.8) 1.3  0.6 (1.0–1.6)
FFAs (mol/l)
Control subjects 411  190 (290–531) 502  154 (404–600)
Relatives 443  160 (376–511) 540  204 (450–631)*
RESP 488  195 (348–628) 510  204 (364–655)
NRES 408  128 (338–486) 566  209 (434–699)*
Insulin (pmol/l)
Control subjects 27  8 (22–32) 23  7 (19–27)
Relatives 41  34 (27–55) 39  31 (26–52)
RESP 36  22 (21–52) 36  20 (22–50)
NRES 45  41 (22–69) 40  37 (19–62)
C-peptide (nmol/l)
Control subjects 1.6  0.4 (1.3–1.8) 1.5  0.4 (1.3–1.8)
Relatives 2.3  0.8 (1.9–2.6)** 2.2  1.0 (1.8–2.6)§
RESP 2.4  0.8 (1.9–3.0) 2.3  1.0 (1.6–3.0)
NRES 2.2  0.8 (1.7–2.7) 2.1  1.0 (1.6–2.7)
QUICKI
Control subjects 0.51  0.05 (0.48–0.54) 0.52  0.04 (0.50–0.54)
Relatives 0.47  0.07 (0.45–0.50) 0.48  0.07 (0.46–0.51)
RESP 0.48  0.06 (0.44–0.52) 0.48  0.05 (0.44–0.51)
NRES 0.47  0.07 (0.43–0.51) 0.49  0.08 (0.45–0.53)
Insulinogenic index
Control subjects 4.3  1.5 (3.3–5.2) 6.1  4.2 (3.4–8.8)
Relatives 4.8  2.4 (3.8–5.9) 6.0  4.7 (4.0–8.0)
RESP 4.3  2.7 (2.4–6.2) 5.0  3.6 (2.4–7.5)
NRES 5.2  2.2 (4.0–6.5) 6.8  5.4 (3.7–9.9)
Data are means  SD (95% CI). *P 
 0.05 before vs. after exercise; **P 
 0.05 control subjects vs. relatives at baseline; §P 
 0.05 control
subjects vs. relatives after exercise training. NRES, not responding to exercise with stimulation of fATPase; QUICKI, quantitative
insulin-sensitivity check index; RESP, responding to exercise with stimulation of fATPase.
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subjects 1.5  1.0 vs. relatives 5.8  7.5%, P  0.08) (Fig.
4) but were not different after training (control subjects
1.8  1.0 vs. relatives 4.4  5.4%). IMCLs (Fig. 4) and G6P
(data not shown) were not different between groups or
affected by training.
Interestingly, baseline fATPase was higher (P  0.025)
in nonresponders than in responders before exercise
training, but by deﬁnition only increased in responders by

24% (P  0.009) and decreased in nonresponders by

16% (P 
 0.001). Similarly, k1 rose in responders (P 
0.01) and decreased in nonresponders (P  0.02). HCLs
and IMCLs in soleus muscle were comparable before and
after the two training sessions. Baseline IMCLs in tibialis
anterior muscle was similar but decreased by 35% (P 
0.006) in nonresponders after training (data not shown).
Baseline fATPase related positively to VO2 (r  0.300,
P  0.046) and power output (r  0.361, P  0.030) each
at maximum and RCP. This ﬁnding also held true for
fATPase after exercise training (data not shown). Baseline
fATPase correlated positively with OGIS (r  0.360, P 
0.031). HCLs related negatively to OGIS (r  0.675, P 

0.001) and positively to plasma insulin (r  0.761, P 

0.001). Multiple regression analysis revealed that HCLs
and baseline caloric intake explained 
49% of the varia-
tion in baseline OGIS (P  10
5). Changes in fATPase
(before versus after exercise sessions) were neither re-
lated to changes in OGIS (r  0.001, P  0.993) nor to
changes in caloric intake (before versus mean caloric
intake during the intervention week; r  0.078, P  0.665),
which did not relate to each other, respectively (r 
0.201, P  0.261). Multiple regression analysis did not
identify any anthropometric, dietary, or laboratory param-
eters as independent predictors of the postexercise
changes in fATPase.
Associations between SNPs in the NDUFB6 and
PPARGC1A genes and exercise responses of fATPase
and insulin sensitivity. The NDUFB6 SNP, rs540467
G/A, was associated with resistance to stimulation of
fATPase and OGIS upon exercise training (Table 4). Exer-
cise training increased fATPase in 74% of the G/G carriers
but only in 33% of those carrying the A allele (P  0.02 for
a dominant model). More G/G genotype carriers (84%)
increased OGIS after exercise training than A allele carri-
ers (53%, P  0.05 for a dominant model). The PPARGC1A
SNP (rs8192678, Gly482Ser) related to neither fATPase
nor OGIS responses to exercise training (Table 4).
DISCUSSION
At baseline, relatives and control subjects did not differ in
parameters commonly interfering with insulin sensitivity
and fATPase including age, fat mass, physical activity, and
aerobic capacity. Nevertheless, relatives were slightly less
insulin sensitive based on OGIS, which corresponds to M
values of 
10 mg  kg
1  min
1. The small difference in
OGIS is in line with the variability of insulin sensitivity in
overweight individuals (26), healthy humans, and type 2
diabetic relatives (16) obtained with clamp tests. Severely
insulin-resistant offspring of type 2 diabetic mothers ex-
hibit increases in plasma FFAs, body fat mass, IMCLs, and
HCLs, along with impaired insulin-stimulated glucose
transport/phosphorylation (11). Such individuals have

30% lower fATPase along with 
40% lower muscle
mitochondrial density than healthy humans. In our study,
fATPase was similar to that of the present and previous
control subjects (4,5,8), suggesting that their ATP produc-
tion sufﬁces for nonexercising conditions. This ﬁnding is in
agreement with unchanged mRNA and protein expression
of PGC-1, regulators of mitochondrial biogenesis, and
their downstream effectors in insulin-resistant relatives
(11). However, comparable baseline fATPase values be-
tween relatives and control subjects do not allow conclu-
sions on differences in mitochondrial number/function but
may simply reﬂect normal basal metabolic rates in both
groups. Although overall mitochondrial function can be
reduced in relatives (11), it was found to be normal in
patients with type 2 diabetes at baseline (7,8,27,28) and
was only reduced upon insulin stimulation (7,8). Several
groups have further shown dissociation between the level
of markers for mitochondrial content and in vitro oxida-
tive capacity. Some researchers (29,30) but not others
(6,9) found differences in mitochondrial function adjusted
for mitochondrial mass.
This study demonstrates that short-term exercise
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FIG. 2. Dynamic insulin sensitivity as assessed from the OGTT (OGIS)
in individuals without (CON, n  12) or with (REL, n  24) ﬁrst-degree
relatives with type 2 diabetes and in relative subgroups responding
(RESP, n  10) or not responding (NRES, n  14) with increased ATP
synthesis after exercise training sessions. Black horizontal bars indi-
cate mean values of the respective groups. *P  0.049 CON before
versus after; **P  0.012 REL before versus after; †P  0.009 RESP
before versus after; ‡P  0.012 CON versus REL before; §P  0.003,
CON versus RESP before; $P  0.031 CON versus RESP after exercise.
0
4
8
12
16
20
µ
m
o
l
.
m
l
-
1
.
m
i
n
-
1
before before before after after after 
exercise
after before
CON REL RES NRES
** * † $ ‡ *
FIG. 3. Skeletal muscle fATPase in individuals without (CON, n  12)
or with (REL, n  24) ﬁrst-degree relatives with type 2 diabetes and in
REL subgroups responding (RESP, n  10) or not responding (NRES,
n  14) with increased ATP synthesis after exercise training sessions.
Black horizontal bars indicate mean values of the respective groups.
*P < 0.001 CON and NRES before versus after; **P  0.002, CON
versus REL after; †P  0.010 CON versus RESP before; $P  0.009
RESP before versus after; §P  0.024 RESP versus NRES before; ‡P <
0.001 CON versus NRES after exercise.
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rate as assessed with fATPase independently of insulin
sensitivity in healthy humans and 2) does not affect
mean fATPase in relatives but 3) identiﬁes subgroups of
relatives with different exercise responses. In some
relatives, these conditions unmask a variation to in-
crease ATP production, reﬂecting altered adaptation of
the basal metabolic rate to short-term exercise training.
In the face of normal fasting glucose and FFAs, hered-
itary factors seem to play an important role, as this
variation in response to exercise training was also seen
in carriers of the A allele of the NDUFB6 SNP, rs540467,
which has been associated with impaired insulin action
and type 2 diabetes risk (12).
Several mechanisms could explain the rise in fTAPase in
control subjects and in responders. Whereas long-term
exercise training possibly stimulates fat oxidation (18,19)
and electron transport chain activity (31) through in-
creased mitochondrial size/number (19,32), it is unlikely
that mitochondrial biogenesis contributed to the rise in
fATPase after a short duration of training. Of note, it is
conceivable that even if mitochondrial capacity is im-
paired, putative regulators of oxidative phosphorylation
could increase and maintain the balance between ATP
demand and supply and thereby baseline fATPase. We
detected a variation occurring despite normal basal
fATPase in insulin-sensitive relatives. In nonresponders, the
decreased fATPase affected adaptation of the myocellular
basal metabolic rate and could therefore reﬂect reduced
need or sufﬁcient capability to supply ATP to meet energy
demands or result from impaired oxidative ATP produc-
tion (33).
This study also shows that IMCLs were not different
from baseline at 48 h after 1 week of three bouts of
exercise. Interestingly, nonresponders had higher plasma
FFAs, suggesting that increased lipid availability could
contribute to impaired fATPase (5), although this might
alternatively lead to increased mitochondrial function and
biogenesis as demonstrated in rodent models (34,35). Fat
oxidation may rise regardless of insulin sensitivity even
after 1 week of exercise training because of increased
expression of enzymes involved in lipid metabolism (36).
At 48 h after one bout of exercise, insulin-stimulated
glucose disposal (16,26) and IMCLs can be increased or
unchanged (17,37). Within 12 h after moderate- to high-
intensity exercise, whole-body oxygen consumption re-
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FIG. 4. Absolute changes (; means  SE) in dynamic insulin sensitivity (OGIS) (A), fATPase (B), and lipid concentrations in liver (HCL) (C)
and soleus muscle (IMCL) (D) in individuals without (CON, n  12) or with (REL, n  24) ﬁrst-degree relatives with type 2 diabetes and in REL
subgroups responding (RESP, n  10) or not responding (NRES, n  14) with increased ATP synthesis after exercise training sessions. *P  0.005
CON versus REL; **P < 0.001 RESP versus NRES; §P < 0.001 CON versus NRES; †P  0.014 REL versus RESP; $P  0.024 REL versus NRES.
TABLE 4
Association between SNPs in the NDUFB6 (rs540467) and
PPARGC1A (rs8192678, Gly482Ser) genes and response to exer-
cise training regarding stimulation of fATPase and dynamic
insulin sensitivity (OGIS) in RESP and NRES
G/G G/A A/A P values
NDUFB6 rs540467
fATPase
RESP 14 4 1 0.02*
NRES 5 9 1
OGIS
RESP 16 7 1 0.05*
NRES 3 6 1
Gly/Gly Gly/Ser Ser/Ser P values
PPARGC1A rs8192678
fATPase
RESP 9 10 0 0.24
NRES 7 6 2
OGIS
RESP 11 11 2 0.64
NRES 5 5 0

2 tests were performed to analyze associations between genotypes
and response to exercise for fATPase and OGIS. *P value indicating
signiﬁcance for a dominant model. NRES, not responding to exercise
with stimulation of fATPase; RESP, responding to exercise with
stimulation of fATPase.
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resynthesis and lipid oxidation continued to rise up to 	40
h (38,39). The postexercise rise in fATPase would thereby
result from increased ATP demand for augmented lipid
turnover. Of note, a portion of the Pi/ATP exchange
may be catalyzed by glyceraldehyde-3-phosphate dehy-
drogenase and 3-phosphoglycerate kinase. Although the
contribution of anaerobic glycolysis to muscular ATP
production is relevant during initial states of exercise and
short-time high-intensity exercise, it ceases in the absence
of muscle contraction and during aerobic resting condi-
tions (40,41). Of note, despite the known negative relation-
ship between HCLs and insulin sensitivity at baseline (14),
the insulin sensitivity improved after exercise training
despite no reductions in IMCLs and HCLs. This is an
important ﬁnding of the study, pointing to independent
regulation of insulin sensitivity and ectopic lipids by
short-term exercise training.
The absent fATPase response in nonresponders was
recorded at 48 h after the last bout of exercise, when
insulin secretion, G6P, pH, and IMCLs were not altered in
all groups. Thus, acute effects occurring within the ﬁrst
24 h after exercise such as stimulation of intramyocellular
glucose transport/phosphorylation (42) and IMCL deple-
tion (26,37) probably did not contribute to fATPase alter-
ations. Of note, exercise training slightly but signiﬁcantly
stimulated insulin sensitivity in both groups in agreement
with previous studies in relatives of type 2 diabetic pa-
tients (16). Insulin-resistant relatives responded to 6-week
of endurance training with increased insulin sensitivity
and substrate oxidation (10,16). On the other hand, com-
bined diet and training for 2 weeks was required to
improve insulin sensitivity and IMCLs in type 2 diabetes
(43). However, in the present study, insulin sensitivity
failed to explain the fATPase response, suggesting that
effects of short-term exercise training on mitochondrial
function and insulin sensitivity can be dissociated in
skeletal muscle. Although one cannot exclude the possi-
bility that mitochondrial oxidation rises before changes in
insulin sensitivity in healthy humans, previous studies
measuring muscular metabolites and enzyme activities
reported that lactate, phosphocreatine hydrolysis, and
glycogen depletion are reduced after 5 days of training,
whereas maximal succinate dehydrogenase activity as a
surrogate of mitochondrial function increased only after
31 days (44). As insulin action was impaired in endurance-
trained individuals who stop exercise training, despite
unchanged oxidative capacity (45), mechanisms other
than oxidative capacity such as muscle glycogen synthesis
probably contribute to changes in OGIS. At 48 h after one
bout of exercising, overweight insulin-resistant relatives
improved their insulin-stimulated glucose disposal associ-
ated with increased glycogen synthesis (16). This result
suggests that increased glycogen storage mainly accounts
for improved insulin action after exercise (46). Because
our patients were not consuming a hypercaloric diet, their
glycogen stores were probably not replenished to preex-
ercise levels, which is known to be an important modula-
tor of insulin sensitivity for at least 72 h after the last
exercise session (46).
The A allele carriers of the NDUFB6 SNP, rs540467,
showed a variation in the response to exercise in line with
an inherited difference. NDUFB6 is among the genes
encoding the respiratory chain, which show lower muscu-
lar expression in type 2 diabetic patients than in control
subjects (47). This SNP was also associated with resis-
tance to an increase in OGIS after exercise training in line
with a reported relationship with glucose disposal and risk
of type 2 diabetes (12). The present study further supports
the important role for this gene in ATP production in
humans in vivo but cannot indicate whether these adapta-
tions were related to changes in mitochondrial number,
localization, or function. In this context it is of note that
activation of peroxisome proliferator–activated receptors
might improve insulin sensitivity by transcriptional control
of mitochondrial function because of enhanced fatty acid
oxidation and regulation of aerobic capacity. The Botnia
study identiﬁed a common variant in the peroxisome
proliferator-activated receptor- gene (P12A) as one of the
best predictors of future development of type 2 diabetes
(48). Recent data provide evidence that even within 300
min after one bout of exercise expression and activation of
PGC-1, AMP-dependent protein kinase phosphorylation,
nuclear respiratory factor-1, and cytochrome c oxidase are
increased in lean but not in insulin-resistant obese humans
(49). Although previous studies suggested roles for
PPARGC1A in oxidative phosphorylation, insulin action,
VO2max, and exercise response (12,13,47,49), in the present
study we did not ﬁnd such associations for the PPARGC1A
Gly482Ser gene variant probably because of lack of
statistical power. Also, longer duration of training might
be needed to reveal the effects of this gene variant, as
PPARGC1A Gly482Ser predicts endurance capacity
(50).
The present study has some limitations. First, quantita-
tive differences from previous studies might be due to the
exercise protocols, degree of insulin resistance, or the
individual exercise capacity. To control for variations in
exercise capacity, participants were exercising at 90% of
their RCP, the highest work load at which oxidative
phosphorylation is adequate for energy demand (51).
Second, minor changes in amount and timing of caloric
intake relative to exercise could have modulated OGIS and
fATPase (52), but unchanged caloric intake and identical
timing of meals render this possibility unlikely. Third,
glucose ingestion during the OGTT before MRS measure-
ments could have differentially affected fATPase. How-
ever, the absence of differences in plasma glucose
between groups at 150 min of the OGTT and the start of
MRS after a further 2 hours and fATPase does not support
such an effect. Fourth, fATPase could have been affected
by alterations of ATP concentrations, which can increase
up to 18 h after exercise (53). Such a rise in ATP would
have led to lower fATPase values, thereby underestimating
the actual ATP synthase ﬂux. However, the observation of
unchanged ATP/PDE ratios and the timing of measure-
ment at 48 h after the last bout of exercise do not support
alterations of ATP levels. Moreover, exchange rates, k1,
which do not depend on substrate concentrations, be-
haved similarly to fATPase between and within groups
before and after training, underlining the fact that the
observed differences reﬂect variation in ATP synthase ﬂux.
Finally, no muscle biopsies were taken so that neither
mass-adjusted mitochondrial function nor possible changes
in the expression of transcriptional modulators could be
assessed. Unchanged plasma RBP-4 and visfatin do not
exclude altered expression/activity of these factors.
In conclusion, training-induced increases of insulin sen-
sitivity and ATP synthesis indicate an important role of
early adaptation of basal metabolic rate in healthy hu-
mans. Conversely, some relatives do not stimulate ATP
production in response to short-term exercise training nor
G. KACEROVSKY-BIELESZ AND ASSOCIATES
DIABETES, VOL. 58, JUNE 2009 1339do they have improved insulin sensitivity, and these same
individuals carry a risk polymorphism in the NDUFB6
gene.
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